Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Neoantigen Vaccine + Durvalumab for Small Cell Lung Cancer
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial is testing a new vaccine for lung cancer. The hope is that it will help people with lung cancer live longer without the disease getting worse.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.